{"ORPHApacket":[{"ORPHApacketID":"133","date":"2019-12-05 17:46:28","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"133","Name":[{"lang":"en","label":"Chronic beryllium disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_133","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Pneumoconiosis"}],"ORPHA":"182098","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_182098"},{"Name":[{"lang":"en","label":"Disease associated with a genetic susceptibility or tested for a biomarker"}],"ORPHA":"231957","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231957"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Chronic beryllium disease (CBD) is a granulomatous, interstitial lung disease that occurs in individuals who develop beryllium sensitization (BeS), a cell-mediated immune response to environmental and occupational beryllium exposure. BeS precedes the lung disease that may present with chronic dry cough, fatigue, weight loss, chest pain, and increasing dyspnea."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Berylliosis"},{"lang":"en","label":"Chronic berylliosis"},{"lang":"en","label":"Chronic beryllium lung disease"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"major histocompatibility complex, class II, DP beta 1"}],"Symbol":"HLA-DPB1","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"4940"},{"Source":"OMIM","Reference":"142858"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317345","Name":[{"lang":"en","label":"Major susceptibility factor in"}]}]}]}]}]}